Michael Garrison, PhD

WW President, BD Surgery, Becton Dickinson

Affiliate Associate Professor, Department of Bioengineering, University of Washington

Dr. Garrison is the WW President of the Becton Dickinson (BD) Interventional-Surgery Business Unit, responsible for developing advanced solutions for tissue reconstruction, optimized surgical process outcomes, infection risk reduction, and palliative care. Prior to his current position, Mike has held a series of roles of increasing technical and business responsibility including: WW Vice-President and General Manager, BD Infusion Solutions, Vice President of R&D, BD Medication and Procedural Solutions, Senior Business Director, BD Hypodermic and Anesthesia Systems, and Director of Advanced Technology. Prior to BD, Dr. Garrison served as Manager of R&D for the surgical heart valve franchise at Edwards Lifesciences, Global Marketing Manager at Roche Diagnostics, and as a Research Scientist at Cygnus Therapeutic Systems. Dr. Garrison received BS and MS degrees in biomedical engineering from Duke University, and a PhD in bioengineering from the University of Washington, where he was advised by Dr. Buddy Ratner. He currently and previously has served on the boards of a number of investment companies of BD. He is currently an Affiliate Associate Professor in the University of Washington Department of Bioengineering.